What is the recommended dilution for epinephrine (adrenaline) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dilution and Administration Guidelines

For anaphylaxis management, epinephrine should be administered intramuscularly in the anterolateral thigh at a concentration of 1:1000 (1 mg/mL) at a dose of 0.01 mg/kg up to 0.5 mg in adults and 0.3 mg in children. 1, 2, 3

Intramuscular (IM) Administration for Anaphylaxis

Standard Dosing by Weight

  • Adults and children ≥30 kg (66 lbs): 0.3-0.5 mg (0.3-0.5 mL) of 1:1000 solution 3
  • Children 25-30 kg (55-66 lbs): 0.3 mg (0.3 mL) of 1:1000 solution 2
  • Children 10-25 kg (22-55 lbs): 0.15 mg (0.15 mL) of 1:1000 solution 2
  • Children <10 kg: 0.01 mg/kg (0.01 mL/kg) of 1:1000 solution 2, 3

Administration Technique

  • Inject into the anterolateral aspect of the thigh (vastus lateralis muscle) 1, 2, 3
  • May be administered through clothing if necessary 3
  • Use a needle long enough (at least 1/2 inch to 5/8 inch) to ensure intramuscular delivery 3
  • May repeat every 5-15 minutes as necessary based on clinical response 1, 3
  • Do not administer repeated injections at the same site (risk of tissue necrosis) 3

Intravenous (IV) Administration

For Anaphylactic Shock Unresponsive to IM Epinephrine

  • Bolus option: 0.05-0.1 mg (0.5-1 mL of 1:10,000 solution) 1
  • Infusion preparation: Add 1 mg (1 mL of 1:1000) epinephrine to 1000 mL of normal saline 1
    • Start at 2 μg/min (2 mL/min or 120 mL/hr)
    • May increase up to 10 μg/min (10 mL/min or 600 mL/hr)
    • Titrate according to blood pressure, cardiac rate, and oxygenation 1

Alternative IV Preparation

  • For continuous infusion: 1 mg of 1:1000 epinephrine in 250 mL D5W (concentration 4.0 μg/mL) 2
    • Infusion rate: 1-4 μg/min (15-60 drops/min with microdrop apparatus)
    • For severe cases: 0.1-1.0 μg/kg/min, with higher doses up to 5 μg/kg/min possible 2

For Septic Shock (Different Indication)

  • Dilute 10 mL (1 mg) of epinephrine in 1,000 mL of 5% dextrose solution (1 μg/mL) 4
  • Infusion rate: 0.05-2 μg/kg/min, titrated to achieve desired mean arterial pressure 4

Important Clinical Considerations

Safety and Monitoring

  • No absolute contraindication to epinephrine in anaphylaxis, even in patients with cardiovascular disease 1, 2
  • Monitor patients receiving epinephrine with continuous cardiac monitoring, frequent BP measurements, and pulse oximetry 2
  • All patients who receive epinephrine should be observed for at least 4-6 hours, with extended observation for those requiring multiple doses 2

Common Pitfalls to Avoid

  1. Delayed administration - associated with increased morbidity and mortality 2, 5
  2. Incorrect route - IM is preferred over subcutaneous for faster absorption 2, 6
  3. Incorrect site - thigh is preferred over arm for faster absorption 1, 2
  4. Underdosing - use appropriate weight-based dosing 2
  5. Overreliance on antihistamines - epinephrine is the first-line treatment 1, 2

Potential Adverse Effects

  • Common: anxiety, tremor, dizziness, sweating, palpitations, pallor, nausea, headache 2
  • Rare but serious: ventricular arrhythmias, hypertension, angina 2, 7
  • IV administration carries higher risk of potentially lethal arrhythmias 2

Epinephrine remains the cornerstone of anaphylaxis management, and its prompt administration can be lifesaving. The benefits of appropriate epinephrine administration far outweigh the risks in anaphylaxis management 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacokinetics of epinephrine/adrenaline autoinjectors.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.